SCHEMBL6318812

SCHEMBL6318812

CCC(=O)Nc1ccc(NC(=C2C(=O)Nc3ccccc32)c2ccccc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.52
ALDH1A1 P00352 5/20 0.52
HPGD P15428 3/20 0.52
MAPT P10636 4/20 0.48
GAA P10253 2/20 0.48
KMT2A Q03164 6/20 0.47
MEN1 O00255 5/20 0.47
NPC1 O15118 4/20 0.47
IDO1 P14902 2/20 0.47
TDO2 P48775 1/20 0.47
SMN1; SMN2 Q16637 3/20 0.46
CYP1A2 P05177 1/20 0.46
POLB P06746 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
CASP3 P42574 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6318809 1.00 RAB9A (0.52) RAB9AALDH1A1HPGDMAPTGAA
SCHEMBL6319706 0.87 IDO1 (0.42) ALDH1A1MAPTIDO1TDO2L3MBTL1
SCHEMBL6319713 0.87 IDO1 (0.42) ALDH1A1MAPTIDO1TDO2L3MBTL1
SCHEMBL6326011 0.87 HPGD (0.51) RAB9AALDH1A1HPGDMAPTNPC1
SCHEMBL6326013 0.87 HPGD (0.51) RAB9AALDH1A1HPGDMAPTNPC1
Hydrochloric Acid SCHEMBL6319875 0.87 KDR (0.42) RAB9AALDH1A1HPGDMAPTKMT2A
Hydrochloric Acid SCHEMBL6319870 0.87 KDR (0.42) RAB9AALDH1A1HPGDMAPTKMT2A
Hydrochloric Acid SCHEMBL6322276 0.87 ALDH1A1 (0.49) RAB9AALDH1A1HPGDMAPTGAA
Hydrochloric Acid SCHEMBL6321114 0.87 ALDH1A1 (0.49) RAB9AALDH1A1HPGDMAPTGAA
SCHEMBL6320790 0.86 ALDH1A1 (0.49) RAB9AALDH1A1HPGDMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6855710-B2 Substituted indolines with an inhibitory effect on various kinases and complexes of CDKs BOEHRINGER INGELHEIM PHARMA KG (DE) 2005-02-15 US disclosed
US-20040058978-A1 Novel substituted indolines with an inhibitory effect on various kinases and complexes of CDKs BOEHRINGER INGELHEIM PHARMA KG (DE) 2004-03-25 US disclosed
EP-1115704-B1 NOVEL SUBSTITUTED INDOLINONES WITH AN INHIBITORY EFFECT ON VARIOUS KINASES AND CYCLIN/CDK COMPLEXES BOEHRINGER INGELHEIM PHARMA (DE) 2003-06-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040058978-A1 Novel substituted indolines with an inhibitory effect on various kinases and complexes of CDKs CDK1, CDK2, CDK3 RAB9A 2092/4885ALDH1A1 1810/4885HPGD 1930/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.